Our services
We combine strategic, analytic and communications expertise to demonstrate your product’s value throughout its lifecycle. We work closely with our clients to characterise each product’s unique value and challenges, then use our deep understanding of payer requirements and processes to develop the best solutions.
Our integrated offering means we can work with you from early value propositions and scenario modelling, through evidence synthesis, data analytics, HTA submission and value communication.
Our systematic reviews are conducted in accordance with internationally recognised guidelines and meet the standards of HTA bodies. We have specialist expertise in evidence synthesis and provide resourceful, innovative solutions based on data availability and jurisdiction requirements.
Our statistical team are experts in the full range of analyses required to inform economic evaluations, as well as in evidence synthesis and design and analysis of clinical trials, observational studies and real-world evidence datasets. We can also advise on the strategic implications of different analytical approaches for HTA.
We are experts in modelling for every stage of your product’s life cycle, including early decision-making models, pricing models, cost-effectiveness and budget impact models, and interactive payer-facing modelling tools.
We can help identify the most robust real-world data for your needs and design studies to inform clinical strategy, enhance market access and support regulatory submissions.
Our first-class strategic, technical and communications expertise makes us outstanding partners for your HTA submissions.
We combine our deep understanding of payer evidence requirements with our communications expertise to develop materials that demonstrate value to payers, clinicians and decision-makers.
